Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChoPS: Cholestyramine vs Prednisolone in Overt Hyperthyroidism
NCT03303053Phase 3Unknown
- Sponsor
- Clinical Research Malaysia
- Start
- May 2017
- Primary completion
- Mar 2018
- Modality
- Device-based Delivery, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cholestyramine, prednisolone in hyperthyroidism, Graves' disease, sponsored by Clinical Research Malaysia. Status: unknown.
02
Drugs
cholestyramineprednisolone
03
Conditions
hyperthyroidismGraves' disease
Beyond the preview
Go deeper on NCT03303053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303053.